CIK: 0001595855
Total reported value
$759.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | OCUL | Ocular Therapeutix INC | Stock-Other | 13.19% | -1.88% | +9.61% | |
| 2 | HROW | Harrow INC | Stock-Other | 11.30% | -12.10% | +2.63% | |
| 3 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 7.56% | +0.24% | +2.93% | |
| 4 | KROS | Keros Therapeutics INC | Stock-Other | 5.30% | — | +2.80% | |
| 5 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 4.86% | — | -15.57% | |
| 6 | CPRX | Catalyst Pharmaceuticals INC | Stock-Healthcare | 3.49% | — | -20.11% | |
| 7 | ARVN | Arvinas INC | Stock-Other | 2.97% | — | +25.14% | |
| 8 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 2.90% | — | — | |
| 9 | JSPR | Jasper Therapeutics INC | Stock-Other | 2.79% | — | — | |
| 10 | EWTX | Edgewise Therapeutics INC | Stock-Other | 2.64% | +0.43% | -4.86% | |
| 11 | APLT | Applied Therapeutics INC | Stock-Other | 2.62% | — | +62.01% | |
| 12 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 2.39% | +0.14% | NEW | |
| 13 | CDXS | Codexis INC | Stock-Other | 2.37% | — | +2.45% | |
| 14 | TARA | Protara Therapeutic INC | Stock-Other | 2.35% | — | — | |
| 15 | ✓ | Acelyrin INC | Stock-Other | 2.32% | — | -61.89% | |
| 16 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 2.14% | — | -31.71% | |
| 17 | ETON | Eton Pharmaceuticals INC | Stock-Other | 2.00% | +2.92% | -3.32% | |
| 18 | TRVI | Trevi Therapeutics INC | Stock-Other | 1.99% | — | +4.34% | |
| 19 | LYEL | Lyell Immunopharma, Inc. | Stock-Other | 1.63% | — | — | |
| 20 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 1.63% | — | +18.84% | |
| 21 | VTYXUSD | Ventyx Biosciences INC | Stock-Other | 1.54% | -0.30% | EXIT | |
| 22 | NTLA | Intellia Therapeutics INC | Stock-Other | 1.53% | +0.41% | NEW | |
| 23 | CMPX | Compass Therapeutics INC | Stock-Other | 1.37% | — | — | |
| 24 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.31% | +0.21% | — | |
| 25 | LQDA | Liquidia CORP | Stock-Other | 1.27% | +0.49% | -11.24% | |
| 26 | PCVX | Vaxcyte INC | Stock-Other | 1.27% | — | -5.56% | |
| 27 | ✓ | Nyxoah S A | Stock-Other | 0.94% | — | -7.19% | |
| 28 | SVRA | Savara INC | Stock-Other | 0.93% | — | — | |
| 29 | SYRS | Syros Pharmaceuticals INC | Stock-Other | 0.92% | — | +119.15% | |
| 30 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.88% | +2.56% | -15.63% | |
| 31 | NRIX | Nurix Therapeutics INC | Stock-Other | 0.86% | — | — | |
| 32 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 0.84% | — | — | |
| 33 | RLMD | Relmada Therapeutics INC | Stock-Other | 0.77% | +0.26% | -13.46% | |
| 34 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.71% | +0.18% | — | |
| 35 | GOSS 5 06-01-27 | Gossamer Bio INC | Stock-Other | 0.70% | — | — | |
| 36 | ZNTL | Zentalis Pharmaceuticals INC | Stock-Other | 0.69% | +0.19% | — | |
| 37 | ALLKGUSD | Allakos INC | Stock-Other | 0.67% | — | — | |
| 38 | GOSS | Gossamer Bio INC | Stock-Other | 0.63% | -1.11% | EXIT | |
| 39 | IBIO | Ibio INC | Stock-Other | 0.60% | — | — | |
| 40 | VSTM | Verastem INC | Stock-Other | 0.54% | — | — | |
| 41 | ✓ | Aligos Therapeutics INC | Stock-Other | 0.35% | — | +25.67% | |
| 42 | CNTX | Context Therapeutics INC | Stock-Other | 0.33% | — | +13.68% | |
| 43 | PGEN | Precigen INC | Stock-Other | 0.30% | — | -6.42% | |
| 44 | LRMR | Larimar Therapeutics INC | Stock-Other | 0.29% | — | -72.03% | |
| 45 | FULC | Fulcrum Therapeutics INC | Stock-Other | 0.27% | — | — | |
| 46 | MOR2 | Morphosys AG Adr | Stock-Other | 0.26% | — | -55.17% | |
| 47 | GKOS | Glaukos CORP | Stock-Healthcare | 0.18% | — | — | |
| 48 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 0.17% | — | — | |
| 49 | ✓ | Biodesix INC | Stock-Other | 0.17% | — | +7.69% | |
| 50 | RGLS | Regulus Therapeutics INC | Stock-Other | 0.11% | — | — |